Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis.
Indian J Ophthalmol
;
2011 July; 59(4): 318-319
Artículo
en Inglés
| IMSEAR
| ID: sea-136200
ABSTRACT
The purpose of the study was to report a case of choroidal neovascularization (CNV) secondary to ocular toxoplasmosis in an 18-year-old female patient. She was treated with a single intravitreal injection of ranibizumab. The CNV resolved as confirmed by fluorescein angiography and optical coherence tomography (OCT). The visual acuity improved to 20/30, which was maintained till the last follow-up visit at two years, without requisition of a repeat injection.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Enfermedades de la Retina
/
Femenino
/
Humanos
/
Angiografía con Fluoresceína
/
Enfermedades de la Coroides
/
Toxoplasmosis Ocular
/
Adolescente
/
Cicatriz
/
Neovascularización Coroidal
/
Inhibidores de la Angiogénesis
Idioma:
Inglés
Revista:
Indian J Ophthalmol
Año:
2011
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS